News section

home  |  news  |  solutions  |  forum  |  careers  |  calendar  |  yellow pages  |  advertise  |  contacts

 

Delta and Pine Land Company announces first quarter fiscal 2006 operating results, acquisition of an Indian seed company
Scott, Mississippi
January 6, 2006

Delta and Pine Land Company (NYSE: DLP - "D&PL" or the "Company"), a leading commercial breeder, producer and marketer of cotton planting seed, today announced results for its first quarter ended November 30, 2005. Due to the seasonal nature of the seed business, the Company typically incurs losses in its first and fourth fiscal quarters.

After charges of $0.02 per diluted share related to Pharmacia/Monsanto litigation expenses and $0.01 per diluted share related to recording the cumulative effect of a change in accounting for stock options upon initial adoption of Statement of Financial Accounting Standards No. 123 (Revised 2004), Share-based Payment ("SFAS 123R"), net loss for the 2006 first quarter was $0.27 per diluted share, an increase from last year's first quarter net loss of $0.12 per diluted share. In the prior year first quarter, Pharmacia/Monsanto litigation expenses were $0.03 per diluted share and there was no cumulative effect of a change in accounting principle.

Revenues were $9.8 million in the 2006 first quarter, compared to $17.5 million recorded in the year-ago quarter. The revenue decrease was attributable to international operations, particularly in South America and Australia. Sales volumes in South America were lower, primarily due to a reduction in the cotton acreage planted in Brazil. Sales volumes in Australia were impacted by increased competition. Results were also impacted in the first quarter of 2006 by increased spending on research and development activities related to new technologies from Monsanto, Syngenta and DuPont, higher professional services fees related to litigation (other than the Pharmacia/Monsanto lawsuit), and stock-based compensation costs.

Indian Acquisition

D&PL also announced that it has acquired Vikki's Agrotech Pvt. Ltd., an Indian cottonseed company. Vikki's has licenses to Monsanto's Bollgard® and Bollgard II® technologies for India as well as rights to commercialize Bt genes from another party. Subject to regulatory approvals being received, Vikki's may commercialize Bollgard® hybrids in India in 2006. The Company continues to consider other acquisition opportunities in the Indian market. D&PL has also established a research program in Northern India to develop products for the Punjab region of both India and Pakistan.

Tom Jagodinski, President and Chief Executive Officer, said, "We are very pleased with the acquisition of Vikki's, which further expands our international presence, providing D&PL with a platform in the Indian cottonseed market. This transaction further builds on our expansion efforts in India and will enable the Company to launch additional research initiatives in India."

Mr. Jagodinski continued, "In addition, we continue to introgress the second generation Monsanto insect resistant and herbicide tolerance traits into our most elite material. We expect to launch as many as eight new varieties containing these technologies in 2006 and expect to have enough seed to plant approximately 1,500,000 acres with seed containing these new traits. Moreover, we continue to dedicate resources to the development of the traits we have licensed from Syngenta and DuPont, which are expected to be launched later this decade.

Share Repurchase Program

From September 1, 2005 through December 31, 2005, D&PL repurchased 320,000 shares at an aggregate purchase price of approximately $7.6 million under the June 30, 2005, share repurchase program. The Company expects to repurchase shares under this plan over time and through a variety of methods, which generally will include open market purchases. The timing and amount of repurchases under this program will depend on market conditions, legal restrictions and other factors.

2006 Earnings Outlook

For the fiscal year 2006, D&PL expects to report earnings per diluted share in the range of $1.10 to $1.20, after charges of $0.10 per diluted share related to its lawsuit against Pharmacia and Monsanto. The Company reported earnings of $1.08 per diluted share in fiscal 2005, after a reduction of $0.07 per diluted share related to Pharmacia/Monsanto litigation expenses. The 2006 guidance takes into consideration additional revenues expected to be derived from higher technology fees from Monsanto's new traits and seed mix changes, partially offset by additional costs related to product development and the launch of new technologies from Monsanto, costs related to the development of Dupont and Syngenta technologies, expenses related to share- based compensation and sales and marketing expenses.

Earnings are significantly affected by planted cotton acreage in the U.S. Based on current market conditions (primarily commodity prices and the cost of inputs), the Company expects cotton plantings in the U.S. to remain constant with or to increase slightly over 2005 plantings of 14.2 million acres, especially in areas east of Texas. The Company's earnings guidance is based on cotton acreage that is flat with 2005 as well as assumptions regarding the maintenance of our market share and product/sales mix targets being met.

Delta and Pine Land Company is a leading commercial breeder, producer and marketer of cotton planting seed. Headquartered in Scott, Mississippi, with multiple offices in eight states and facilities in several foreign countries, D&PL also breeds, produces and markets soybean planting seed in the U.S.

xxx

                 DELTA AND PINE LAND COMPANY AND SUBSIDIARIES
                    CONSOLIDATED STATEMENTS OF OPERATIONS
                          FOR THE THREE MONTHS ENDED
                   (in thousands, except per share amounts)
                                 (Unaudited)

                                                   November 30,   November 30,
                                                      2005           2004
                                                   ------------   ------------

    NET SALES AND LICENSING FEES                      $9,825        $17,454
    COST OF SALES                                      6,663          8,421
                                                   ------------   ------------
    GROSS PROFIT                                       3,162          9,033
                                                   ------------   -----------
    OPERATING EXPENSES:
      Research and development                         5,605          4,430
      Selling                                          3,398          3,066
      General and administrative                       6,119          4,539
                                                   ------------   -----------
                                                      15,122         12,035
                                                   ------------   -----------
    OPERATING LOSS                                   (11,960)        (3,002)

    INTEREST INCOME, NET                               1,028            458
    OTHER EXPENSE, NET                                (1,203)        (1,507)
    EQUITY IN NET LOSS OF AFFILIATE                     (814)          (738)
    MINORITY INTEREST IN EARNINGS OF SUBSIDIARIES       (832)        (2,336)
                                                   ------------   -----------
    LOSS BEFORE INCOME TAXES                         (13,781)        (7,125)
    INCOME TAX BENEFIT                                (4,488)        (2,808)
                                                   ------------   -----------
    LOSS BEFORE CUMULATIVE
     EFFECT OF ACCOUNTING CHANGE                      (9,293)        (4,317)

    CUMULATIVE EFFECT OF ACCOUNTING
     CHANGE, NET OF TAX                                 (358)            --
                                                   ------------   -----------
    NET LOSS                                          (9,651)        (4,317)

    DIVIDENDS ON PREFERRED STOCK                        (160)          (128)
                                                   ------------   -----------
    NET LOSS APPLICABLE TO COMMON SHARES             $(9,811)       $(4,445)
                                                   ============   ===========
    BASIC AND DILUTED NET LOSS
     PER SHARE, BEFORE CUMULATIVE
     EFFECT OF ACCOUNTING CHANGE                      $(0.26)        $(0.12)
                                                   ============   ===========
    CUMULATIVE EFFECT OF ACCOUNTING CHANGE            $(0.01)           $--
                                                   ============   ===========
    BASIC AND DILUTED NET LOSS PER SHARE              $(0.27)        $(0.12)
                                                   ============   ===========
    NUMBER OF SHARES USED IN BASIC
     AND DILUTED NET LOSS PER SHARE
     CALCULATIONS                                     36,074         38,544
                                                   ============   ===========
    DIVIDENDS PER COMMON SHARE                         $0.15          $0.12
                                                   ============   ===========



                 DELTA AND PINE LAND COMPANY AND SUBSIDIARIES
                         CONSOLIDATED BALANCE SHEETS
              (in thousands, except share and per share amounts)
                                 (Unaudited)

                                  November 30,    August 31,   November 30,
                                      2005           2005          2004
    ASSETS                        -----------     ----------   ------------
    CURRENT ASSETS:
    Cash and cash equivalents       $61,148         $93,075      $121,222
    Receivables, net                 13,596         228,800        15,332
    Inventories                      66,222          26,625        62,039
    Prepaid expenses                  1,503           1,874         1,547
    Deferred income taxes             6,372           6,305         6,598
                                  -----------     ----------    -----------
      Total current assets          148,841         356,679       206,738

    PROPERTY, PLANT AND
     EQUIPMENT, NET                  60,409          60,158        62,299
    EXCESS OF COST OVER NET
     ASSETS OF BUSINESSES
     ACQUIRED                         4,183           4,183         4,183
    INTANGIBLES, net                  5,999           5,960         5,489
    OTHER ASSETS                      1,562           1,446         1,608
    DEFERRED INCOME TAXES            10,563          10,758         7,600
                                  -----------     ----------    -----------
    TOTAL ASSETS                   $231,557        $439,184      $287,917
                                  ===========     ==========    ===========
    LIABILITIES AND
     STOCKHOLDERS' EQUITY
    CURRENT LIABILITIES:
    Notes payable                    $8,300         $10,078       $11,318
    Accounts payable                 25,767          18,218        22,955
    Accrued expenses                 39,135         221,824        29,735
    Income taxes payable              3,898          12,893         2,377
                                  -----------     ----------    -----------
      Total current liabilities      77,100         263,013        66,385
                                  -----------     ----------    -----------
    LONG-TERM DEBT                    3,363           7,271        11,001
    MINORITY INTEREST IN          -----------     ----------    -----------
     SUBSIDIARIES                     5,709           4,877         6,563
                                  -----------     ----------    -----------
    DEFERRED COMPENSATION               403              --            --
                                  -----------     ----------    -----------
    STOCKHOLDERS' EQUITY:
    Preferred stock, par value
     $0.10 per share;
     2,000,000 shares authorized
      Series A Junior Participating
       Preferred, par value $0.10 per
       share; 501,989, 456,989,
       456,989 shares authorized;
       no shares issued or
       outstanding;                      --              --            --
      Series M Convertible Non-Voting
       Preferred, par value $0.l0 per
       share; 1,066,667 shares
       authorized, issued
       and outstanding                  107             107           107
    Common stock, par value $0.10 per
     share; 100,000,000 shares
     authorized; 40,944,440,
     40,928,929 and 40,247,696 shares
     issued; 35,900,334, 36,099,823
     and 38,580,230 shares
     outstanding                      4,094           4,093         4,025
    Capital in excess of par value   82,694          81,640        66,127
    Retained earnings               184,542         199,742       167,734
    Accumulated other
     comprehensive loss              (4,060)         (4,305)       (2,306)
    Treasury stock, at cost;
     5,044,106, 4,829,106 and
     1,667,466 shares              (122,395)       (117,254)      (31,719)
                                  -----------     -----------    ----------
    TOTAL STOCKHOLDERS' EQUITY      144,982         164,023       203,968
    TOTAL LIABILITIES AND         -----------     -----------    ----------
     STOCKHOLDERS' EQUITY          $231,557        $439,184      $287,917
                                  ===========     ===========    ==========



                 DELTA AND PINE LAND COMPANY AND SUBSIDIARIES
                    CONSOLIDATED STATEMENTS OF CASH FLOWS
                          FOR THE THREE MONTHS ENDED
                                (in thousands)
                                 (Unaudited)

                                                     November      November
                                                     30, 2005      30, 2004
                                                    ----------    ----------
    CASH FLOWS FROM OPERATING ACTIVITIES:
      Net loss                                       $(9,651)       $(4,317)
      Adjustments to reconcile net loss
       to net cash used in operating
       activities:
        Depreciation and amortization                  2,155          2,226
        Loss (gain) on sale of assets                     28           (10)
        Equity in net loss of affiliate                  814            738
        Foreign exchange gain                           (183)          (106)
        Accretion of debt discount                       113            194
        Minority interest in earnings of subsidiaries    832          2,336
        Stock-based compensation expense                 660             --
        Change in deferred income taxes                  123          3,209
        Cumulative effect of accounting change           555             --
        Changes in assets and liabilities:
          Receivables                                215,141        169,892
          Inventories                                (39,469)       (31,778)
          Prepaid expenses                               373            371
          Intangibles and other assets                  (242)          (254)
          Accounts payable                             7,410        (1,194)
          Accrued expenses                          (182,843)      (158,203)
          Income taxes                                (8,990)        (6,397)
                                                    ---------      ---------
         Net cash used in operating activities       (13,174)       (23,293)
                                                    ---------      ---------
    CASH FLOWS FROM INVESTING ACTIVITIES:
      Purchases of property and equipment             (2,350)        (1,781)
      Sale of investments and property                    23             12
      Investment in affiliate                           (700)          (800)
                                                    ---------      ---------
         Net cash used in investing activities        (3,027)        (2,569)
                                                    ---------      ---------
    CASH FLOWS FROM FINANCING ACTIVITIES:
      Payments of short-term debt                     (5,800)            --
      Dividends paid                                  (5,549)        (4,757)
      Minority interest in dividends paid
       by subsidiary                                      --           (359)
      Payments to acquire treasury stock              (5,141)            --
      Proceeds from exercise of stock options            231          1,675
                                                    ---------      ---------
         Net cash used in financing activities       (16,259)        (3,441)
                                                    ---------      ---------
    EFFECTS OF FOREIGN CURRENCY EXCHANGE RATES           533            938

    NET DECREASE IN CASH AND CASH EQUIVALENTS        (31,927)       (28,365)
    CASH AND CASH EQUIVALENTS, August 31              93,075        149,587
                                                    ---------      ---------
    CASH AND CASH EQUIVALENTS, November 30           $61,148       $121,222
                                                    =========      =========
    SUPPLEMENTAL CASH FLOW INFORMATION:
      Cash paid during the three months for:
        Interest, net of capitalized interest            $--            $--
        Income taxes paid/(refunded)                  $3,437          $(128)

      Non-cash financing activities:
        Tax benefit of stock option exercises            $12           $211
News release

Other news from this source

14,499

Back to main news page

The news release or news item on this page is copyright © 2006 by the organization where it originated.
The content of the SeedQuest website is copyright © 1992-2006 by SeedQuest - All rights reserved
Fair Use Notice